MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 73 filers reported holding OYSTER PT PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q2 2020$6,498,000
-17.5%
225,0000.0%0.50%
-0.4%
Q1 2020$7,875,000
+43.2%
225,0000.0%0.51%
+93.5%
Q4 2019$5,499,000225,0000.26%
Other shareholders
OYSTER PT PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$32,226,00014.34%
Paradigm Biocapital Advisors LP 987,698$11,497,0003.04%
NEA Management Company, LLC 5,925,287$68,970,0001.99%
KPCB XIV Associates, LLC 367,987$4,283,0001.61%
Telemark Asset Management, LLC 787,026$9,161,0000.81%
COWEN AND COMPANY, LLC 509,794$5,934,0000.57%
RTW INVESTMENTS, LP 2,058,504$23,961,0000.50%
ACT CAPITAL MANAGEMENT, LLC 13,500$157,0000.17%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$12,101,0000.11%
Wildcat Capital Management, LLC 36,847$429,0000.11%
View complete list of OYSTER PT PHARMA INC shareholders